Clinical Trials/Research : Trials
Trials
ISCI Clinical Trials |
|||
| Status Start Date |
Study Title [Number] |
Phase | Contact Information |
| Active, Not Recruiting 03/10/08 |
A Phase I/II, Randomized, Double-Blinded, Placebo-Controlled Study of the Safety and Efficacy of Intramyocardial Injection of Autologous Human Mesenchymal Stem Cells (MSCs) in Patients With Chronic Ischemic Left Ventricular Dysfunction Secondary to Myocardial Infarction (MI) Undergoing Cardiac Surgery for Coronary Artery Bypass Grafting (CABG). (Research Type: Drug | Study Type: Others | Division: Cardiology | Therapeutic Area: Other) [20070598 – NIH/NHLBI – Hare | See "Prometheus" at ClinicalTrials.gov] |
Phase I/II | Darcy Velazquez Study Coordinator 305-243-9106 |
| Enrolling 5/1/09 |
A randomized Study to Evaluate to the Safety of Bone Marrow Aspirate Plus Cultured Bone Marrow Cells Versus Bone Marrow Aspirate Alone Versus Cultured Bone Marrow Aspirate Cells Alone in the Treatment of Chornic Wounds. (Research Type: Other | Study Type: Others | Division: Dermatology | Therapeutic Area: Wound Healing) [20080299 – NIH/NIA – Badiavas] | Phase I/II | Carol Kittles Study Coordinator 305-243-8485 |
| Enrolling 7/14/08 |
A Phase I/II, Randomized, Double-Blinded, Placebo-Controlled Study of the Safety and Efficacy of Transendocardial Injection of Autologous Human Cells (Bone Marrow or Mesenchymal) in Patients with Chronic Ischemic Heart Failure Secondary to Myocardial Infarction. The Transendocardial Autologous Cells (hMSC or hBMC) in Ischemic Heart Failure Trial (TAC-HFT). (Research Type: Other | Study Type: Therapeutic | Division: Cardiology | Therapeutic Area: Other) [20070443 – Biocardia – Heldman | See "TAC-HFT" at ClinicalTrials.gov] | Phase I/II | Darcy Velazquez Study Coordinator 305-243-9106 |
Enrolling |
Gene Expression Profiling and Prognosis in Cardiomyopathy. (Research Type: Specimen | Study Type: Others | Division: Cardiology | Therapeutic Area: Other) [20070495 – Intramural – Hare] | N/A | Darcy Velazquez Study Coordinator 305-243-9106 |
| Enrolling 9/10/07 |
A Phase II, multi-center, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of PROCHYMAL® (ex vivo cultured adult human mesenchymal stem cells) intravenous infusion following acute myocardial infarction: The Osiris 403 study. (Research Type: Drug | Study Type: Others | Division: Cardiology | Therapeutic Area: Other) [20090602 – OSIRIS – HELDMAN | See "Osiris" at ClinicalTrials.gov] | Phase II | Darcy Velazquez Study Coordinator 305-243-9106 |
| Active, Not Recruiting 9/21/09 |
A Phase I/II, Randomized Pilot Study of the Comparative Safety and Efficacy of Transendocardial Injection of Autologous Mesenchymal Stem Cells Versus Allogeneic Mesenchymal Stem Cells in Patients With Chronic Ischemic Left Ventricular Dysfunction Secondary to Myocardial Infarction. The Percutaneous Stem Cell Injection Delivery Effects On Neomyogenesis Pilot Study (The POSEIDON-Pilot Study). (Research Type: Other | Study Type: Others | Division: Cardiology | Therapeutic Area: Other) [20090352 – NIH-NHLBI BioCardia – Hare | See "Poseiden" at ClinicalTrials.gov] | Phase I/II | Darcy Velazquez Study Coordinator 305-243-9106 |
| Enrolling 6/1/11 |
A Phase I/II, Randomized, Pilot Study of the Comparative Safety and Efficacy of Transendocardial Injection of Autologous Mesenchymal Stem Cells (MSC) versus Allogeneic MCS in Patients with Nonischemic Dilated Cardiomyopathy. (Poseidon DCM). | Phase I/II | Darcy Velazquez Study Coordinator 305-243-9106 |